Products found to contain undeclared medicines
|
| |
| Australia: Counterfeit 'honey' sachets for sexual enhancement |
| |
The Therapeutic Goods Administration (TGA) advises consumers that sexual enhancement products labelled as ‘honey’ may pose a serious risk to your health and should not be taken.
The TGA has tested the following imported unapproved products and found that they contain undeclared tadalafil:
- Black Horse Honey sachets
- Royal Honey VIP sachets
- Vital Honey sachets
- Helmi's Honey sachets
- Etumax Royal Honey sachets
Tadalafil is regulated as a prescription-only medicine in Australia and should only be used under medical supervision. Tadalafil taken alone or in combination with other medicines can cause serious side effects. Tadalafil may interact with nitrates found in some prescription medicines and may lower blood pressure to dangerous levels. Nitrates are often prescribed for people with diabetes, high blood pressure, high cholesterol or heart disease.
The products tested by the TGA are considered counterfeit under the Therapeutic Goods Act 1989. Counterfeit products cannot be imported under the Personal Importation Scheme. Knowingly importing, supplying and/or giving away counterfeit therapeutic goods is illegal and poses a significant public health and safety risk.
Consumers are advised to stop using the tested 'honey' branded sexual enhancement products listed above and take any remaining product to their local pharmacy for safe disposal. If they have any concerns arising from their use of this product, consult their healthcare practitioner.
Please refer to the following website in TGA for details:
http://www.tga.gov.au/safety/safety-monitoring-and-information/../counterfeit-honey-sachets-sexual-enhancement
In Hong Kong, the above products are not registered pharmaceutical products. Related news was previously issued by the United States Food and Drug Administration and Health Canada, and was posted on the Drug Office website since 18 Jul 2017, with the latest update posted on 20 Jul 2022.
Ends/Thursday, Jul 9, 2026
Issued at HKT 15:30
|
| |
|
